Scynexis (SCYX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov17

SCYNEXIS Receives Federal Grant for Novel Antifungal Drug Development

15:16

Nov6

Scynexis released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 334K (forecast USD 147.67K), actual EPS USD -0.1721 (forecast USD -0.2)

04:00

Scynexis released FY2025 9 Months Earnings on November 5, 2025 (EST) with actual revenue of USD 1.955 M and EPS of USD -0.4205

04:00

Oct16

Jason McCarthy Recommends Buying SCYNEXIS

17:17

Oct1

Jason McCarthy Gives SCYNEXIS a Buy Rating

20:06

Aug14

Scynexis released FY2025 Semi-Annual earnings on August 13 (EST), actual revenue USD 1.62 M, actual EPS USD -0.2475

03:00

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 334 K, Net Income -8.591 M, EPS -0.1721

Aug13

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.364 M, Net Income -6.885 M, EPS -0.1383

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 257 K, Net Income -5.391 M, EPS -0.11

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change